Fiorella David, Albuquerque Felipe C, McDougall Cameron G
Department of Neurosurgery and Neuroradiology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Neurosurgery. 2006 Jan;58(1):51-9; discussion 51-9. doi: 10.1227/01.neu.0000194190.45595.9e.
Matrix detachable coils (MDC; Boston Scientific/Target, Fremont, CA) are platinum coils coated with a bioabsorbable polymeric material (polyglycolic-polylactic acid). In animal models, the introduction of polyglycolic-polylactic acid-coated coils into experimental aneurysms resulted in a cellular reaction which promoted stable intra-aneurysmal scar tissue formation. The current study was undertaken to assess the durability of aneurysm occlusion after embolization with MDC.
All patients undergoing embolization were prospectively enrolled in an endovascular database at our institution. All coils used for embolization were recorded in the operative notes for the procedure. Only aneurysms embolized with 50% or greater length of MDC were included. All patients with Neuroform stents (Boston Scientific/Target, Fremont, CA) were excluded from the study. Patients were followed with conventional angiography and magnetic resonance angiography.
During a 20-month period, 131 aneurysms were embolized with MDC. Follow up data (average, 6.9 mo; range, 1.5-22 mo) were available for 82 aneurysms (61 with conventional angiography, 21 with magnetic resonance angiography only). Of the aneurysm patients with follow-up available, 65 had small aneurysms with small necks, three were small aneurysms with wide necks, 12 were large aneurysms, and two were giant aneurysms. Overall, there were 30 (36.6%) recanalizations, 19 (23.1%) of which required retreatment. In two additional patients, retreatment was either recommended (n = 1) or attempted unsuccessfully (n = 1). Fifty-two aneurysms were unchanged or demonstrated progressive thrombosis (63.4%). The recanalization rate for small aneurysms with small necks was 26.1% (17 out of 65) with a 13.8% retreatment rate (9/65). The recanalization rate for large aneurysms was 75% (9 out of 12) with seven requiring retreatment.
In the absence of Neuroform stent support, aneurysms embolized with the MDC system demonstrated a significant rate of recanalization. Many of the recanalizations were of sufficient size to warrant retreatment. The rates of recanalization observed in the present series were comparable to, or worse than, those reported for bare platinum coils.
基质可分离线圈(MDC;波士顿科学公司/Target,弗里蒙特,加利福尼亚州)是涂有生物可吸收聚合物材料(聚乙醇酸 - 聚乳酸)的铂线圈。在动物模型中,将涂有聚乙醇酸 - 聚乳酸的线圈引入实验性动脉瘤会引发细胞反应,从而促进动脉瘤内稳定的瘢痕组织形成。本研究旨在评估用MDC栓塞后动脉瘤闭塞的耐久性。
所有接受栓塞治疗的患者均前瞻性地纳入我们机构的血管内数据库。所有用于栓塞的线圈均记录在该手术的手术记录中。仅纳入用MDC栓塞长度达50%或更长的动脉瘤。所有使用Neuroform支架(波士顿科学公司/Target,弗里蒙特,加利福尼亚州)的患者均被排除在本研究之外。对患者进行传统血管造影和磁共振血管造影随访。
在20个月期间,131个动脉瘤用MDC进行了栓塞。82个动脉瘤(61个采用传统血管造影,21个仅采用磁共振血管造影)有随访数据(平均6.9个月;范围1.5 - 22个月)。在有随访数据的动脉瘤患者中,65个是小动脉瘤且颈部较小,3个是小动脉瘤且颈部较宽,12个是大动脉瘤,2个是巨大动脉瘤。总体而言,有30例(36.6%)再通,其中19例(23.1%)需要再次治疗。另外2例患者中,1例被建议再次治疗,1例尝试再次治疗但未成功。52个动脉瘤未发生变化或显示血栓形成进展(63.4%)。颈部较小的小动脉瘤再通率为26.1%(65个中有17个),再次治疗率为13.8%(9/65)。大动脉瘤的再通率为75%(12个中有9个),其中7个需要再次治疗。
在没有Neuroform支架支持的情况下,用MDC系统栓塞的动脉瘤显示出较高的再通率。许多再通的动脉瘤大小足以需要再次治疗。本系列中观察到的再通率与裸铂线圈报道的再通率相当或更差。